Wish Bone

Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will present new results from its clinical studies with blinatumomab at the 51st annual meeting of the American Society of Hematology from December 5-8, 2009 in New Orleans, Louisiana. Read More

Clarient, Inc. , a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that privately held, Waltham, MA-based Minerva Biotechnologies has granted it the exclusive right to develop and commercialize a test that identifies the MUC1* protein, a biomarker researchers believe may be implicated in the spread of many cancers, including breast cancer. Read More

Roemer FW et al. – Whole organ magnetic resonance imaging (MRI)–based semiquantitative (SQ) assessment of knee osteoarthritis (OA), based on reliable scoring methods and expert reading, has become a powerful research tool in OA. Read More

Our weekly look at the upcoming schedule and the Fantasy impact in all the games. Read More

In a report from Adam Schefter on ESPN.com, Eli Manning may have a bit more than plantar fasciitis to worry about in regards to his right foot. Read More